Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Status:
Terminated
Trial end date:
2011-07-05
Target enrollment:
Participant gender:
Summary
Current therapies for Stage IV adrenal gland cancer provide very limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of Stage IV adrenal gland cancer
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Stage IV adrenal gland cancer.